ZBH Zimmer Biomet Holdings Inc

  1. Stocks
  2. Healthcare
  3. NYSE: ZBH

Price (delayed)

$111.29

Market cap

$22.9B

P/E Ratio

23.98

Dividend/share

$0.96

EPS

$4.64

Enterprise value

$28.3B

Zimmer Biomet is a publicly traded medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of ...

Highlights
ZBH's P/E is 75% lower than its 5-year quarterly average of 94.6 and 42% lower than its last 4 quarters average of 40.9
The revenue has grown by 4.9% YoY
The EPS has soared by 118% YoY but it has contracted by 5% from the previous quarter
The net income has surged by 114% year-on-year but it has declined by 6% since the previous quarter
ZBH's quick ratio is down by 10% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://www.zimmerbiomet.com/
Peers: BSX COO SYK EW

Key stats

What are the main financial stats of ZBH
Market
Shares outstanding
205.73M
Market cap
$22.9B
Enterprise value
$28.3B
Valuations
Price to earnings (P/E)
23.98
Price to book (P/B)
1.81
Price to sales (P/S)
3.06
EV/EBIT
23.62
EV/EBITDA
13.12
EV/Sales
3.8
Earnings
Revenue
$7.45B
EBIT
$1.2B
EBITDA
$2.16B
Free cash flow
$792.6M
Per share
EPS
$4.64
Free cash flow per share
$3.86
Book value per share
$61.43
Revenue per share
$36.32
TBVPS
$38.63
Balance sheet
Total assets
$21.45B
Total liabilities
$8.85B
Debt
$5.8B
Equity
$12.6B
Working capital
$1.83B
Liquidity
Debt to equity
0.46
Current ratio
1.66
Quick ratio
0.66
Net debt/EBITDA
2.51
Margins
EBITDA margin
28.9%
Gross margin
71.9%
Net margin
12.9%
Operating margin
16.3%
Efficiency
Return on assets
4.5%
Return on equity
7.7%
Return on invested capital
11.3%
Return on capital employed
6.4%
Return on sales
16.1%
Dividend
Dividend yield
0.86%
DPS
$0.96
Payout ratio
20.7%

ZBH stock price

How has the Zimmer Biomet Holdings stock price performed over time
Intraday
0.59%
1 week
0.71%
1 month
2.94%
1 year
-21.53%
YTD
-8.55%
QTD
2.54%

Financial performance

How have Zimmer Biomet Holdings's revenue and profit performed over time
Revenue
$7.45B
Gross profit
$5.36B
Operating income
$1.22B
Net income
$963.9M
Gross margin
71.9%
Net margin
12.9%
The net income has surged by 114% year-on-year but it has declined by 6% since the previous quarter
The net margin has surged by 105% year-on-year but it has declined by 7% since the previous quarter
Zimmer Biomet Holdings's operating income has increased by 47% YoY but it has decreased by 4.8% QoQ
Zimmer Biomet Holdings's operating margin has increased by 41% YoY but it has decreased by 6% QoQ

Growth

What is Zimmer Biomet Holdings's growth rate over time

Valuation

What is Zimmer Biomet Holdings stock price valuation
ZBH P/E details
P/E
23.98
P/B
1.81
P/S
3.06
EV/EBIT
23.62
EV/EBITDA
13.12
EV/Sales
3.8
The EPS has soared by 118% YoY but it has contracted by 5% from the previous quarter
ZBH's P/E is 75% lower than its 5-year quarterly average of 94.6 and 42% lower than its last 4 quarters average of 40.9
The stock's P/B is 18% below its 5-year quarterly average of 2.2 and 14% below its last 4 quarters average of 2.1
ZBH's equity is up by 3.7% year-on-year
ZBH's price to sales (P/S) is 22% lower than its 5-year quarterly average of 3.9 and 15% lower than its last 4 quarters average of 3.6
The revenue has grown by 4.9% YoY

Efficiency

How efficient is Zimmer Biomet Holdings business performance
The ROA has soared by 114% YoY but it has contracted by 6% from the previous quarter
Zimmer Biomet Holdings's return on equity has surged by 108% YoY but it has decreased by 7% QoQ
The ROIC has soared by 55% YoY but it has decreased by 6% QoQ
The ROS has soared by 50% YoY but it has contracted by 6% from the previous quarter

Dividends

What is ZBH's dividend history
Dividend details
DPS
$0.96
Dividend yield
0.86%
Payout ratio
20.7%
Recent dividends

Financial health

How did Zimmer Biomet Holdings financials performed over time
The total assets is 142% higher than the total liabilities
The current ratio has contracted by 12% YoY but it has grown by 3.1% from the previous quarter
ZBH's quick ratio is down by 10% YoY
The debt is 54% smaller than the equity
ZBH's equity is up by 3.7% year-on-year
The debt to equity has declined by 4.2% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.